Item 5.07. Submission of Matters to a Vote of Security Holders.

On Wednesday, June 1, 2022, Rain Therapeutics Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "2022 Annual Meeting") at 10:00 a.m. Pacific Time. As of the close of business on April 7, 2022, the record date for the 2022 Annual Meeting, there were 18,799,405 shares of the Company's voting common stock issued and outstanding. At the 2022 Annual Meeting, each of the Company's director nominees was elected and the other proposal voted on was approved. The final voting results are set forth below:



                                               Votes            Votes           Broker
                                                For           Withheld         Non-Votes
Proposal 1. Election of Class I Directors
?  Aaron Davis                                8,418,005        1,841,899        3,520,142
?  Gorjan Hrustanovic, Ph.D.                  9,059,104        1,200,800        3,520,142




                                              Votes         Votes                       Broker
                                               For         Against     Abstentions     Non-Votes
Proposal 2. Ratification of Ernst &
Young LLP as Independent Auditor            13,778,188       709          1,149            0

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses